ABSTRACT BACKGROUND: Social recognition underlies social behavior in animals, and patients with psychiatric disorders associated with social deficits show abnormalities in social recognition. Oxytocin is implicated in social behavior and has received attention as an effective treatment for sociobehavioral deficits. Secretin receptor-deficient mice show deficits in social behavior. The relationship between oxytocin and secretin concerning social behavior remains to be determined. METHODS: Expression of c-Fos in oxytocin neurons and release of oxytocin from their dendrites after secretin application were investigated. Social recognition was examined after intracerebroventricular or local injection of secretin, oxytocin, or an oxytocin receptor antagonist in rats, oxytocin receptor-deficient mice, and secretin receptor-deficient mice. Electron and light microscopic immunohistochemical analysis was also performed to determine whether oxytocin neurons extend their dendrites into the medial amygdala. RESULTS: Supraoptic oxytocin neurons expressed the secretin receptor. Secretin activated supraoptic oxytocin neurons and facilitated oxytocin release from dendrites. Secretin increased acquisition of social recognition in an oxytocin receptor-dependent manner. Local application of secretin into the supraoptic nucleus facilitated social recognition, and this facilitation was blocked by an oxytocin receptor antagonist injected into, but not outside of, the medial amygdala. In the medial amygdala, dendrite-like thick oxytocin processes were found to extend from the supraoptic nucleus. Furthermore, oxytocin treatment restored deficits of social recognition in secretin receptordeficient mice. CONCLUSIONS: The results of our study demonstrate that secretin-induced dendritic oxytocin release from supraoptic neurons enhances social recognition. The newly defined secretin-oxytocin system may lead to a possible treatment for social deficits.
Oxytocin, a nonapeptide hormone, is primarily synthesized in magnocellular and parvocellular neurons of the hypothalamic paraventricular nucleus (PVN) and in magnocellular neurons of the supraoptic nucleus (SON) in the hypothalamus, and it is modestly expressed in the bed nucleus of the stria terminalis (1, 2) . Oxytocin in magnocellular neurons is released from the neurohypophysis into the systemic circulation and has roles in parturition and lactation (3) . Oxytocin is also released from axon terminals of parvocellular oxytocin neurons and from dendrites or cell bodies of magnocellular oxytocin neurons (4, 5) . The oxytocin receptor is distributed widely within the brain, including the olfactory bulb, basal ganglia, hypothalamus, limbic areas, and brainstem (3, 6) , suggesting that oxytocin has various functions in the central nervous system. Growing evidence has shown that oxytocin modulates social recognition and social behavior. Animal studies showed that oxytocin increases social interactions and is involved in partner preference and parental behavior (7) (8) (9) (10) . Oxytocin-deficient and oxytocin receptordeficient mice show sociobehavioral deficits (11, 12) . Oxytocin has also been implicated in disorders associated with dysfunctional social behaviors, including autism spectrum disorders (10, (13) (14) (15) . For improving social deficits in humans, activation of endogenous oxytocin neurons, rather than exogenous oxytocin administration, the reported effects of which are controversial, has been proposed to be effective (16) .
Secretin, a 27-amino acid peptide hormone that belongs to the vasoactive intestinal peptide/glucagon/pituitary adenylate cyclase-active polypeptide family (17) , has also been suggested to play a role in the control of social behavior. Secretin is synthesized in various brain regions, including the hypothalamus, hippocampus, cerebellum, cerebral cortex, and brainstem (18) (19) (20) (21) . The secretin receptor is also distributed widely in the brain, including the brainstem, cerebellum, cerebral cortex, hypothalamus, and hippocampus (21) (22) (23) (24) . Secretin receptor-deficient mice have been suggested to have deficits in social behavior (25) .
METHODS AND MATERIALS Animals
Male Wistar rats and male and female C57BL/6J mice were obtained from Japan SLC, Inc. (Shizuoka, Japan), CLEA Japan, Inc. (Tokyo, Japan), or Charles River Laboratories Japan (Kanagawa, Japan). Oxytocin receptor-deficient male mice (12) and secretin receptor-deficient male mice (25) after backcrossing with C57BL/6J mice for .11 generations were used. Adult male animals were used in the present study except where specified otherwise. Juvenile male rats and ovariectomized female C57BL/6J mice were used as stimulus animals for the social recognition test, and 4-week-old male rats were used for experiments with isolated SON. The animals were housed in a room with controlled temperature (22 6 21C) and humidity (40%-70%) with a 12-hour light/dark cycle (lights on 7:30 AM-7:30 PM). Food and water were available ad libitum. All animals except the ones used in the experiment, for which results are shown in Figure 1B 
Social Recognition Test
A juvenile male rat (21-35 days old) or an ovariectomized female mouse (.10 weeks old) was presented to an adult male rat or mouse, respectively, for 4 minutes (training session). After an interval (30 minutes or 45 minutes), both the same stimulus animal (familiar) and another stimulus animal (novel) were presented for 4 minutes (test session). Social recognition was estimated by using a preference index ([time investigating novel animal]/[time investigating familiar animal 1 time investigating novel animal] 3 100) (28) . As social recognition lasts ,40 minutes in rodents (29) , a 45-minute interval between the training and the test was used to assess facilitative effects of drugs on social recognition. A 30-minute posttraining interval was used in tests for which results are shown in Figures 1B and C and 3H , and a 45-minute posttraining interval was used in tests for which results are shown in Figures  1D-F and 3A-C and E. Drugs were injected 10 minutes before the training session, unless otherwise specified.
Surgery and Intracerebroventricular Injection
Animals were anesthetized with intraperitoneal injection of 200 mg/kg tribromoethanol (Avertin; Wako Pure Chemical Industries, Ltd., Osaka, Japan) and placed in a stereotactic frame. Stainless steel guide cannulae (23 gauge for rats or 25 gauge for mice) were inserted into the right lateral cerebral ventricle (coordinates for rats, .6 mm caudal to the bregma, 1.6 mm lateral to the midline, and 4.5 mm below the skull; coordinates for mice, .4 mm caudal to the bregma, 1.0 mm lateral to the midline, and 2.0 mm below the skull) and secured to the skull with screws and dental cement. Animals were allowed to recover in individual cages for 1-2 weeks (rats) or for 2-3 weeks (mice). Animals were given an intracerebroventricular (i.c.v.) injection (30- 
Detection of Activated Neurons After Secretin Injection
For detection of neurons activated after secretin injection, male rats, male secretin receptor-deficient mice, or male oxytocin receptor-deficient mice were given an i.c.v. injection of secretin (1 μg/5 μL [rats] or 1 μg/2 μL [mice]) or the vehicle, anesthetized with intraperitoneal injection of 50 mg/kg pentobarbital (Nembutal; Dainippon Pharmaceutical Co., Ltd., Osaka, Japan) 100 minutes after the injection, and perfused transcardially with heparinized saline (20 U/mL) and then with 4% paraformaldehyde in .1 mol/L phosphate buffer (pH 7.4). The brains were removed, postfixed in 4% paraformaldehyde overnight, and transferred to 30% sucrose solution in .1 ml/L phosphate buffer until tissues sank. The brains were frozen on dry ice and stored at 2801C. Coronal brain sections were cut at 30 μm with a freezing sledge microtome. Every fourth (rats) or third (mice) section of the hypothalamus and medial amygdala was collected and processed for immunohistochemistry for c-Fos or oxytocin or both (2,31) (see Supplemental Methods and Materials in Supplement 1 for details).
X-gal Staining and Immunohistochemistry for Oxytocin
For detection of β-galactosidase activity in oxytocin neurons of the SON in secretin receptor-heterozygous mice, the mice were perfused transcardially with heparinized saline (20 U/mL) and then with 4% paraformaldehyde in .1 mol/L phosphate buffer. Brain sections were cut at 5 μm and processed for X-gal staining and immunohistochemical detection of oxytocin (see Supplemental Methods and Materials in Supplement 1 for details).
Secretin Facilitates Social Recognition via Oxytocin

Measurement of Plasma Oxytocin After Secretin Injection
Trunk blood of rats was collected by decapitation at 5, 15, 30, and 60 minutes after i.c.v. injection of secretin (1 μg/5 μL) or the vehicle for time-course analysis and at 15 minutes after i.c.v. injection of secretin (.1, 1, 10 μg/5 μL) or the vehicle for dose-dependency analysis. Plasma samples were obtained by centrifugation. Plasma concentrations of oxytocin were determined by a radioimmunoassay with specific anti-oxytocin (32) as described previously (33) . Coefficients of intra-assay and interassay variations were 4% and 10% for oxytocin, respectively. The minimum detection limit was 2 pg/mL for oxytocin.
Measurement of Oxytocin Release From Isolated SON
Brains were obtained from male rats (Slc:Wistar; Japan SLC) at 4 weeks of age by decapitation. Two blocks of basal hypothalamic tissues (2 mm 3 1 mm 3 1 mm) containing the SON were dissected out from each brain under a dissecting microscope (31) . The blocks were transferred to normal Locke's buffer solution (140 mmol/L sodium chloride, 5 mmol/L potassium Figure 1 . Secretin facilitates acquisition of social recognition. (A) An adult male rat or mouse (A) was exposed to one stimulus conspecific animal (S1) in a training session. After an interval of 30 minutes or 45 minutes, both the S1 stimulus animal and a novel stimulus animal (S2) were presented in a test session. Because social recognition lasts for ,40 minutes in rodents (29), a 45-minute interval was used to assess facilitative effects of drugs on social recognition. The preference index was calculated as described in Methods and Materials. ) and maintained at 371C throughout the experiments. The normal Locke's buffer solution was changed at 5-minute intervals for 60 minutes before collecting the samples. After the preincubation period, samples were collected every 5 minutes in a volume of 200 μL until the end of the experiment. Secretin at a concentration of 2 μmol/L or 10 μmol/L was applied for 15 minutes. The collected samples were immediately stored at 2801C until radioimmunoassay for oxytocin. Stimulus-evoked hormone release during drug application at each dosage is presented as the amount of hormone released compared with basal release (fraction before application of secretin or the vehicle).
Surgery and Microinjection
Rats were anesthetized with Avertin and placed in a stereotactic frame. Stainless steel guide cannulae (23 gauge) were inserted into the brain so that tips of the injection cannulae were located in the right SON (coordinates for the tips of guide cannulae, 1.8 mm caudal to the bregma, 1.8 mm lateral to the midline, and 7.1 mm below the skull) or the right medial amygdala (coordinates, 2.3 mm caudal to the bregma, 3.2 mm lateral to the midline, and 7.4 mm below the skull) and secured to the skull with screws and dental cement. The tip of the injection needle (30 gauge) extended 1.8 mm beyond the guide cannulae. The position of the tip was verified with methylene blue injected through the cannula after experiments ( Figure S1 in Supplement 1). Animals were allowed to recover from the surgical operation of cannula implantation for 2 weeks. Rats were injected with secretin (.1 μg/.5 μL) or the vehicle into the SON and with an oxytocin receptor antagonist (.1 μg/.5 μL) or artificial cerebrospinal fluid vehicle into the medial amygdala.
Detection of Dendrite-like Processes of Oxytocin Neurons From SON
Male rats were perfused and brains were isolated as described earlier. Coronal brain sections were cut at 50 μm and processed for immunohistochemical detection of oxytocin by use of a light microscope (Supplemental Materials and Methods in Supplement 1).
For electron microscopic examination, male rats were perfused with a solution containing 4% paraformaldehyde, .1% glutaraldehyde, and .3% tannic acid in .1 mol/L phosphate buffer. Brain sections were cut and processed for electron microscopic analysis (34) (Supplemental Methods and Materials in Supplement 1).
Data Analysis
Data were analyzed by the Mann-Whitney U test, Student t test, two-way analysis of variance, or one-way analysis of variance followed by Bonferroni-Dunn or Dunnett's multiple comparison tests. Social recognition data were also analyzed by the Wilcoxon signed rank test (investigation time for familiar mice vs. investigation time for novel mice). A value of p , .05 was considered to be statistically significant.
RESULTS
Mice or rats were exposed to one stimulus conspecific animal in a training session; after an interval, both the previously exposed familiar stimulus animal and a different novel stimulus animal were introduced to the animal ( Figure 1A ). Wild-type mice spent more time investigating a novel mouse than investigating a previously exposed familiar mouse and thus showed a preference index of .50 ( Figure 1B, C) , suggesting that wild-type mice discriminated between novel and familiar mice. On the other hand, secretin receptor-deficient mice ( Figure 1B ) and oxytocin receptor-deficient mice ( Figure 1C ) investigated a novel mouse and familiar mouse equally and thus showed a smaller preference index than wild-type mice, suggesting that not only the oxytocin receptor but also secretin receptor plays a facilitative role in social recognition. This kind of short-term social recognition lasts for ,40 minutes in rodents (29) . Vehicle-injected mice and rats spent similar periods of time investigating the familiar stimulus and novel stimulus animals and thus showed a preference index of 50 when tested 45 minutes after training ( Figure 1D , E), suggesting that rodents no longer discriminated between familiar and novel stimulus animals. However, following secretin administration before the training session, mice and rats spent a longer time investigating the novel stimulus animals at testing than investigating the familiar stimulus animals and thus showed an increased preference index compared with that of vehicleinjected animals, suggesting that secretin facilitated social recognition ( Figure 1D, E) . We then examined whether secretin facilitates acquisition, consolidation, or recall of social recognition. Secretin administration before, but not after, the training facilitated social recognition ( Figure 1F ). These findings suggest that secretin acts in the acquisition phase to facilitate social recognition rather than acting in consolidation or recall.
To clarify whether secretin activates oxytocin neurons, we examined the expression of c-Fos, a marker of neuronal activation, in oxytocin neurons after i.c.v. injection of secretin. The number of c-Fos-positive oxytocin neurons was significantly increased after i.c.v. injection of secretin in the SON but not in the PVN and bed nucleus of the stria terminalis (Figure 2A, B) , suggesting that i.c.v. secretin preferentially activates oxytocin neurons in the SON. To determine whether secretin activates oxytocin neurons via activation of the secretin receptor, we examined the expression of c-Fos in oxytocin neurons of secretin receptor-deficient mice. An increase in the number of c-Fos-positive oxytocin neurons in the SON after secretin injection was blocked in secretin receptor-deficient mice ( Figure 2C ), suggesting that secretin activates oxytocin neurons via the secretin receptor. We then examined whether oxytocin neurons in the SON express the secretin receptor. In order to identify cells expressing the secretin receptor, we examined the expression of β-galactosidase, for which the gene was inserted in a secretin receptorknockout vector as a reporter gene. In secretin receptorheterozygous mice, but not in wild-type mice, β-galactosidase activity was evident in oxytocin neurons in the SON suggesting that oxytocin neurons in the SON express the secretin receptor ( Figure 2D and Figure S2 in Supplement 1).
We then examined whether secretin facilitates oxytocin release. After i.c.v. injection of secretin, the plasma concentration of oxytocin increased and peaked at 5 minutes ( Figure 2E ), and the increase was dose dependent ( Figure 2F ). Blood hemoglobin concentration, plasma osmolality, and plasma glucose concentration were not significantly Secretin Facilitates Social Recognition via Oxytocin changed after secretin injection ( Figures S3 and S4 in Supplement 1), suggesting that the increase in oxytocin release observed after secretin injection was not caused by changes in blood volume, blood osmolality, or blood glucose concentration. In order to determine whether secretin also facilitates oxytocin release from soma or dendrites, we examined oxytocin release from isolated SON explants. After application of secretin to isolated SON explants, oxytocin concentrations in the perfusates were significantly increased in a dose-related fashion ( Figure 2G, H) . These results suggest that secretin activates oxytocin neurons and facilitates not only peripheral oxytocin release but also somatodendritic oxytocin release.
To determine whether secretin facilitates social recognition via oxytocin, we examined the effects of an oxytocin receptor antagonist. Secretin-induced increase of the preference index was blocked by i.c.v. coadministration of an oxytocin receptor antagonist ( Figure 3A) , suggesting that activation of the oxytocin receptor is essential for facilitation of social recognition by secretin. Furthermore, a secretin-induced increase of the preference index was not observed in oxytocin receptordeficient mice ( Figure 3B ). Because i.c.v. injection of secretin activated oxytocin neurons in the SON (Figure 2A, B) and supraoptic oxytocin neurons expressed the secretin receptor ( Figure 2D ), we examined whether activation of oxytocin neurons in the SON by microinjection of secretin facilitates social recognition. After microinjection of secretin into the SON, rats showed preferential investigation toward novel juvenile stimulus rats and thus showed an increased preference index compared with vehicle-injected rats ( Figure 3C ). However, rats injected with secretin outside of the SON spent similar periods of time investigating the familiar stimulus and novel stimulus rats (Wilcoxon signed rank test, t 5 32, p 5 .9292) and thus showed a preference index of 50 (49.7 6 2.9, mean 6 SEM, n 5 11). These results suggest that secretin acted within or in the vicinity of the SON to facilitate social recognition.
The oxytocin receptor is expressed in the medial amygdala (6), and oxytocin has been shown to act on the medial amygdala to facilitate social recognition (26) . It is possible that secretin activates oxytocin neurons in the SON, stimulates the oxytocin receptor in the medial amygdala, and as a result facilitates social recognition. Consistent with this view, we found that i.c.v. administration of secretin resulted in an increase in the number of c-Fos-positive cells in the medial amygdala of mice ( Figure 3D ) and rats ( Figure S5 in Supplement 1) and that secretin-induced c-Fos expression was blocked by deficiency of the oxytocin receptor in mice ( Figure 3D ). We further examined the effects of microinjection of an oxytocin receptor antagonist into the medial amygdala. Facilitation of social recognition induced by injection of secretin into the SON was blocked after microinjection of an oxytocin receptor antagonist into the medial amygdala but not after microinjection of the antagonist outside the medial amygdala ( Figure 3E ).
All the results suggest that activation of supraoptic oxytocin neurons induces stimulation of the oxytocin receptor in the medial amygdala. The medial amygdala contains oxytocin fibers, but it has been reported that oxytocin neurons in the SON do not project to the medial amygdala (35) . Thus, we examined whether the medial amygdala contains dendrites of oxytocin neurons, as oxytocin was released from dendrites of oxytocin neurons after application of secretin ( Figure 2G, H) . Oxytocin-immunoreactive ventrally projected thick spinous processes, which are characteristics of oxytocin dendrites, were found to extend from the SON into the anteroventral part of the medial amygdala ( Figure 3F ). Electron microscopic examination revealed that the medial amygdala contained dendrites and axons of oxytocin neurons ( Figure 3G ). These findings are consistent with the idea that oxytocin is released directly in the medial amygdala from dendrites of supraoptic oxytocin neurons.
We also examined the action of oxytocin in secretin receptor-deficient mice. After oxytocin administration, secretin receptor-deficient mice showed preferential investigation toward novel stimulus animals and showed a preference index that was as high as wild-type animals ( Figure 3H ), suggesting that oxytocin restored deficits in social recognition of secretin receptor-deficient mice and that facilitative action of oxytocin on social recognition is not dependent on the secretin receptor.
DISCUSSION
In the present study, we found that secretin facilitates oxytocin release from the SON and facilitates social recognition. Facilitative effects of secretin on social recognition were blocked by a selective oxytocin receptor antagonist injected into the medial amygdala and by deficiency of the oxytocin receptor. These findings suggest that secretin facilitates social recognition via activation of the oxytocin receptor within or in the vicinity of the medial amygdala.
Social recognition memory is composed of at least three phases: acquisition, consolidation, and recall. Oxytocin has been shown to facilitate acquisition of social recognition (26) . It has been suggested that secretin receptor-deficient mice have deficits in social recognition (25) . In the present study, secretin injected before, but not after, the acquisition phase facilitated social recognition memory. These results demonstrated that secretin as well as oxytocin facilitates acquisition, but not consolidation or recall, of social recognition. The results are consistent with the view that secretin facilitates social recognition via the oxytocin-oxytocin receptor system.
Application of secretin to the SON facilitated oxytocin release and enhanced social recognition via the oxytocin receptor within or in the vicinity of the medial amygdala. It remains to be clarified how stimulation of supraoptic oxytocin neurons induced activation of the oxytocin receptor in the medial amygdala. Stimulation of supraoptic oxytocin neurons might have induced somatodendritic oxytocin release within the SON, from where released oxytocin may reach the medial amygdala by diffusion. Because the medial amygdala contains oxytocin fibers (36), it is also possible that oxytocin was released from oxytocin fibers within the medial amygdala. Electron and light microscopic examinations in the present study demonstrated that both dendrites and axons of oxytocin neurons existed within the medial amygdala and suggested that oxytocin-positive, dendrite-like processes extended from the SON into the anteroventral part of the medial amygdala. Oxytocin-containing axon fibers were reported to originate from oxytocin neurons in the PVN, but not from oxytocin neurons in the SON (35) . These findings are consistent with the view that activation of supraoptic oxytocin neurons induced oxytocin release from dendrites within the SON or dendrites extending from the SON into the medial amygdala and as a result facilitates social recognition. This view does not exclude roles of PVN oxytocin neurons projecting to the medial amygdala in social recognition. Possible functional differences between SON and PVN oxytocin neurons in the control of social recognition remain to be clarified.
The present study suggests involvement of the oxytocinoxytocin receptor system in secretin-induced facilitation of social recognition. However, secretin has been reported to activate hypothalamic vasopressin neurons (21) , and vasopressin has affinity to the oxytocin receptor (37) . Thus, Secretin Facilitates Social Recognition via Oxytocin (38) , which apparently contradicts the observed facilitative action of secretin on acquisition of social recognition. Roles of vasopressin in the control of social recognition following secretin need to be evaluated by further studies.
Neurosecretory neurons in the SON contain secretory vesicles in their cell bodies and dendrites, and they release peptides packed in the vesicles somatodendritically within the SON (5) . Secretin has been shown to be synthesized and released from magnocellular neurosecretory neurons (21) . The magnocellular oxytocin neurons in the hypothalamus have been suggested to be activated by social stimuli, including affiliative gaze and touches (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) 39, 40) . Considering the results suggesting that the secretin receptor is expressed in oxytocin neurons, it is tempting to speculate that social stimuli activate supraoptic neurosecretory neurons and induce dendritic secretin release within the SON from neurosecretory neurons, leading to activation of the secretin receptor of their own or neighboring neurosecretory neurons to modulate activity of oxytocin neurons and as a result facilitate social recognition.
In the present study, secretin was administered centrally at doses of .1-10 μg. The doses appear to be relatively high, considering the reported in vitro affinity of the secretin receptor binding, as reported values of dissociation constant or inhibition constant were between .2 nmol/L and 20 nmol/L (22, (41) (42) (43) . However, secretin concentrations at action sites of secretin were not determined in the present study. Previous in vivo studies using animals showed that similar doses of secretin that were centrally administered affected behaviors such as food intake, water intake, and locomotion (44) (45) (46) (47) . Furthermore, in the present study, effects of secretin were blocked by deficiency of the secretin receptor, and oxytocin neurons were shown to express the secretin receptor. All these findings suggest that the action of secretin observed in the present study was mediated by the secretin receptor expressed in oxytocin neurons. However, peripheral administration of secretin at a dose of .1-1 μg in rats was reported to activate supraoptic oxytocin neurons and facilitate oxytocin release (48) . This action by peripheral secretin is mediated by central noradrenergic projections to the SON (48) and thus is likely to be distinct from a direct action of secretin on oxytocin neurons suggested by the results of the present study.
In conclusion, our findings provide evidence that oxytocin released somatodendritically from supraoptic oxytocin neurons by local secretin acts on the oxytocin receptor within or in the vicinity of the medial amygdala during the acquisition phase and, as a result, facilitates social recognition. Enhancement of endogenous oxytocin release has been proposed to be most effective for improving social recognition (16) . Pharmacologically inducing dendritic oxytocin release may lead to therapy for psychiatric disorders with social deficits.
